IRVINE, California, July 11, 2019 – Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) and EVERSANA™ have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be designed to leverage EVERSANA’s position as the leading provider of commercial services addressing access, affordability and adherence challenges for cell and […]
Posted on July 11, 20197/11/19
- Pricentric Insights: What a Biden Presidency Could Mean for Drug Pricing in the U.S.
- UK’s MHRA Joins ACSS-Consortium, FDA’s Project Orbis
- Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States
- Japan’s Ministry of Health Proposes Finalized Off-Year Re-pricing for All Medicines
- EMA Commences Rolling Review of Second COVID-19 Vaccine